Opicapone in clinical practice in Parkinson’s disease patients with motor fluctuations and complications of therapy at baseline: findings from the OPTIPARK study
Objective: This post-hoc analysis evaluated the effects of opicapone (OPC) treatment in patients with Parkinson’s disease (PD) who experience motor fluctuations and complications of therapy…Wearable sensor motor outcomes across patients with Parkinson’s disease from Asian, Black, and Caucasian ethnicity in the United Kingdom
Objective: To determine the effect of ethnic background on motor scores in people with Parkinson’s disease (PwP) using objective measurement. Background: Limited evidence has suggested…An Unusual Case of Multiple Systems Atrophy with Long Disease Duration, Severe Gliosis, and Scant Synuclein Pathology
Objective: To describe a pathologically unusual case of Multiple systems atrophy (MSA) with severe widespread gliosis and neuronal loss with scant alpha-synuclein (aSyn) pathology. Background:…An evaluation of the application of clinical research criteria for corticobasal degeneration in a large clinico-pathological series
Objective: To evaluate diagnostic criteria for corticobasal degeneration (CBD) in relation to pathology and disease course. Background: The overlapping features of CBD and related conditions…A Rare Case of Reversible Acute Parkinsonism in Fulminant HIV Encephalopathy
Objective: - Background: HIV infection of the central nervous system can be a result of direct neuroinflammatory processes or by opportunistic infections. Movement disorders in…ELECTRICAL ACTIVITY OF THE MASTICATORY MUSCLES OF PARKINSONIANS INFLUENCED BY THE USE OF REMOVABLE DENTAL PROSTHESIS
Objective: Analyze the influence of the types of dental prosthesis on the electromyographic activity of the masticatory muscles; masseter and temporal anterior in parkinsonians. Background:…Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database
Objective: To describe the development and organization of the Consortium for Global Diversity in Parkinson’s Disease (CDG-PD), created in 2020 with a broad aim to…Prevalence of Suicidal Ideation and Associated Clinical Features in Lewy Body Dementia
Objective: The goal of this study was to identify the prevalence of suicidal ideation (SI) in Lewy body dementia (LBD) and the factors associated with…ASSOCIATION BETWEEN INSULIN RESISTANCE AND DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON´S DISEASE
Objective: The main objective of the study was to analyze the association between insulin resistance (IR ) at diagnosis and the development of dementia in…Reduced Alpha suppression & altered EEG signal complexity in Parkinson’s disease – signatures of cognitive impairment?
Objective: In a cross-sectional setting both alpha suppression and complexity of alpha-band oscillations are evaluated as diagnostic biomarker for assessing MCI in early stages of…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 132
- Next Page »